147 related articles for article (PubMed ID: 32345035)
1. Application of human lymphoid cells for the evaluation of antivirals against human adenovirus type 19: Zalcitabine has superior activity compared to cidofovir.
Nakagawara K; Hayashi H; Kawaji K; Sasano M; Kodama EN
Antivir Chem Chemother; 2020; 28():2040206620921319. PubMed ID: 32345035
[TBL] [Abstract][Full Text] [Related]
2. In vitro co-infection by cytomegalovirus improves the antiviral activity of ganciclovir against human adenovirus.
Aguilar-Guisado M; Marrugal-Lorenzo JA; Berastegui-Cabrera J; Merino L; Pachón J; Sánchez-Céspedes J
Int J Antimicrob Agents; 2020 Aug; 56(2):106046. PubMed ID: 32540429
[TBL] [Abstract][Full Text] [Related]
3. The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution.
Lugthart G; Oomen MA; Jol-van der Zijde CM; Ball LM; Bresters D; Kollen WJ; Smiers FJ; Vermont CL; Bredius RG; Schilham MW; van Tol MJ; Lankester AC
Biol Blood Marrow Transplant; 2015 Feb; 21(2):293-9. PubMed ID: 25464118
[TBL] [Abstract][Full Text] [Related]
4. HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model.
Toth K; Spencer JF; Ying B; Tollefson AE; Wold WSM
Viruses; 2017 Jun; 9(6):. PubMed ID: 28608847
[TBL] [Abstract][Full Text] [Related]
5. Decoy Receptor Interactions as Novel Drug Targets against EKC-Causing Human Adenovirus.
Chandra N; Frängsmyr L; Arnberg N
Viruses; 2019 Mar; 11(3):. PubMed ID: 30870979
[TBL] [Abstract][Full Text] [Related]
6. A rapid quantitative PCR-based assay for testing antiviral agents against human adenoviruses demonstrates type specific differences in ribavirin activity.
Stock R; Harste G; Madisch I; Heim A
Antiviral Res; 2006 Oct; 72(1):34-41. PubMed ID: 16650905
[TBL] [Abstract][Full Text] [Related]
7. Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method.
Kodama E; Shigeta S; Suzuki T; De Clercq E
Antiviral Res; 1996 Jul; 31(3):159-64. PubMed ID: 8811200
[TBL] [Abstract][Full Text] [Related]
8. Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus.
Chamberlain JM; Sortino K; Sethna P; Bae A; Lanier R; Bambara RA; Dewhurst S
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397065
[TBL] [Abstract][Full Text] [Related]
9. Establishing an accurate and sensitive in vitro drug screening system for human adenovirus infection with human corneal cells.
Sasano M; Hayashi H; Kawaji K; Usui E; Kodama EN
Virology; 2023 Apr; 581():34-38. PubMed ID: 36848735
[TBL] [Abstract][Full Text] [Related]
10. Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies.
Dodge MJ; MacNeil KM; Tessier TM; Weinberg JB; Mymryk JS
Antiviral Res; 2021 Apr; 188():105034. PubMed ID: 33577808
[TBL] [Abstract][Full Text] [Related]
11. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949
[TBL] [Abstract][Full Text] [Related]
12. [Which drugs to treat Adenovirus infections?].
Salmona M; Feghoul L; LeGoff J
Virologie (Montrouge); 2021 Feb; 25(1):43-56. PubMed ID: 33650496
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel screening platform for the identification of small molecule inhibitors of human adenovirus.
Saha B; Varette O; Stanford WL; Diallo JS; Parks RJ
Virology; 2019 Dec; 538():24-34. PubMed ID: 31561058
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of antiviral agents for adenovirus using the MTT method in vitro].
Kaneko H; Fujiwara T; Mori S; Shigeta S
Nippon Ganka Gakkai Zasshi; 2000 Nov; 104(11):786-91. PubMed ID: 11530368
[TBL] [Abstract][Full Text] [Related]
15. Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis.
Uchio E; Fuchigami A; Kadonosono K; Hayashi A; Ishiko H; Aoki K; Ohno S
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1319-25. PubMed ID: 17226023
[TBL] [Abstract][Full Text] [Related]
16. Filociclovir is a potent inhibitor of human adenovirus F41.
Tollefson AE; Hussein ITM; Toth K; Bowlin TL
Antiviral Res; 2022 Dec; 208():105431. PubMed ID: 36209985
[TBL] [Abstract][Full Text] [Related]
17. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
Ophthalmology; 2002 May; 109(5):845-50. PubMed ID: 11986086
[TBL] [Abstract][Full Text] [Related]
18. Five new genome types of adenovirus type 37 caused epidemic keratoconjunctivitis in Sapporo, Japan, for more than 10 years.
Ariga T; Shimada Y; Shiratori K; Ohgami K; Yamazaki S; Tagawa Y; Kikuchi M; Miyakita Y; Fujita K; Ishiko H; Aoki K; Ohno S
J Clin Microbiol; 2005 Feb; 43(2):726-32. PubMed ID: 15695671
[TBL] [Abstract][Full Text] [Related]
19. Identification and molecular characterization of adenovirus types (HAdV-8, HAdV-37, HAdV-4, HAdV-3) in an epidemic of keratoconjunctivitis occurred in Pune, Maharashtra, Western India.
Gopalkrishna V; Ganorkar NN; Patil PR
J Med Virol; 2016 Dec; 88(12):2100-2105. PubMed ID: 27152842
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide sequence variation in the hexon gene of human adenovirus type 8 and 37 strains from epidemic keratoconjunctivitis patients in Japan.
Kaneko H; Ishiko H; Ohguchi T; Tagawa Y; Aoki K; Suzutani T; Ohno S
J Gen Virol; 2009 Sep; 90(Pt 9):2260-5. PubMed ID: 19458172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
